beta-Amyloid Peptide (1-42) (human) (ab120301)
Key features and details
- beta-Amyloid (1-42) protein fragment. Implicated in Alzheimer's disease.
- CAS Number: 107761-42-2
Solubility is batch-dependent. Please refer to the Protocol Booklet and the batch-specific CoA for more information.
- Form / State: Solid
- Source: Synthetic
Overview
-
Product name
beta-Amyloid Peptide (1-42) (human) -
Description
beta-Amyloid (1-42) protein fragment. Implicated in Alzheimer's disease. -
Alternative names
- AB42
-
CAS Number
107761-42-2 -
Chemical structure
Properties
-
Molecular weight
4514.08 -
Molecular formula
C203H311N55O60S -
Sequence
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA -
PubChem identifier
57339251 -
Storage instructions
Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months. -
Solubility overview
Solubility is batch-dependent. Please refer to the Protocol Booklet and the batch-specific CoA for more information.
-
Handling
This product is supplied in one (or more) pack size which is freeze dried. Therefore the contents may not be readily visible, as they can coat the bottom or walls of the vial. Please see our FAQs and information page for more details on handling.
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one week. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
Source
Synthetic
-
Research areas
Associated products
-
Related Products
Images
-
Chemical Structure - beta-Amyloid Peptide (1-42) (human) (ab120301)2D chemical structure image of ab120301, beta-Amyloid Peptide (1-42) (human)
References (19)
ab120301 has been referenced in 19 publications.
- Tehrani Z et al. Assessing Surface Coverage of Aminophenyl Bonding Sites on Diazotised Glassy Carbon Electrodes for Optimised Electrochemical Biosensor Performance. Nanomaterials (Basel) 11:N/A (2021). PubMed: 33562051
- Le HTN & Cho S Deciphering the Disaggregation Mechanism of Amyloid Beta Aggregate by 4-(2-Hydroxyethyl)-1-Piperazinepropanesulfonic Acid Using Electrochemical Impedance Spectroscopy. Sensors (Basel) 21:N/A (2021). PubMed: 33503934
- Hark TJ et al. Pulse-Chase Proteomics of the App Knockin Mouse Models of Alzheimer's Disease Reveals that Synaptic Dysfunction Originates in Presynaptic Terminals. Cell Syst 12:141-158.e9 (2021). PubMed: 33326751
- Illouz T et al. Maternal antibodies facilitate Amyloid-ß clearance by activating Fc-receptor-Syk-mediated phagocytosis. Commun Biol 4:329 (2021). PubMed: 33712740
- Mirza FJ et al. Rosmarinic acid and ursolic acid alleviate deficits in cognition, synaptic regulation and adult hippocampal neurogenesis in an Aß1-42-induced mouse model of Alzheimer's disease. Phytomedicine 83:153490 (2021). PubMed: 33601255
